iPerf concludes promising clinical trial of novel dual-lumen femoral arterial cannula for cardiopulmonary support
- No device-related serious adverse events were reported during the first-in-human trial of 15 patients receiving cardiopulmonary support
- NIRS monitoring showed maintained tissue oxygenation in the cannulated limb, with no sign of impaired distal perfusion
- Full results will be presented at the AATS Mechanical Support and Thoracic Transplantation Summit in Toronto on October 2nd, 2026
Read the full press release here